https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

Concession of a hemato-oncology project of GILEAD Sciences to the IDIVAL research group of Translational Hematopathology

28 de October de 2019

Recently, after the evaluation by international experts carried out by the Carlos III Health Institute, the 7th Call for Research Projects on HIV, Liver Diseases and Hemato-oncology of GILEAD Sciences has been resolved in which the “Liquid biopsy for the molecular diagnosis of DLBCL patients treated in clinical trials (GLD19 / 00041)” research project lead by […]

Read more →

Santander will host the next Congress of the National Biobank Network 2020

24 de October de 2019

The candidacy of BIOBANCO VALDECILLA, has been selected for the organization of the XI CONGRESS OF THE NATIONAL BIOBANK NETWORK – SANTANDER 2020 From now on the countdown begins with the clear objective of making it a success both for your organization, as for its contents, speakers and participants. The Congress that will be held in […]

Read more →

Valdecilla researcher patents two devices for the treatment of the open abdomen

22 de October de 2019

Dr. Federico Castillo Suescun, has patented with the help of IDIVAL two devices whose use can contribute to improve the prognosis of patients with an open abdomen, a very serious medical condition, with a mortality rate of 70%. His project is now in search of financing for its development with an improved design and the […]

Read more →

First face-to-face meeting of inDemand mirror regions

11 de October de 2019

        The European Regions Research nd Innovation Network (ERRIN) recently hosted the first face-to-face meeting of the community of 10 mirror regions interested in implementing the inDemand co-creation model to design digital health solutions with local stakeholders. The project’s three pilot regions, Murcia (Spain), Oulu (Finland) and Paris (France) have all seen […]

Read more →

Dr San Segundo appointed member of the Basic Committee of the European Organ Transplant Society

9 de October de 2019

Dr. David San Segundo, immunologist of the HUMV Immunology Service and researcher of the IDIVAL Transplant and Autoimmunity group, has been chosen to be part of the ESOT (European Organ Transplantation Society) Basic Science Committee during the congress held in September in Copenhagen. The Committee is made up of 7 members, with a balanced composition […]

Read more →

Diagnosing dementia through drawings

7 de October de 2019

The Cognitive Impairment Unit of the Marqués de Valdecilla University Hospital has developed a new and original test for the differential diagnosis of dementias. The study, which has been published in the Journal of Alzheimer's Disease, shows how by carrying out four drawings (turtle, strawberry, envelope and train) the researchers were able to diagnose with […]

Read more →

Concession of a Health Research Fund Project FIS to the Cardiovascular Research group

4 de October de 2019

The Cardiovascular Research group led by Dr. De La Torre has obtained funding from the Carlos III Health Institute in the last call of the recently resolved National Plan. Coronary heart disease and its consequences are leaders in morbidity and mortality and resource consumption in developed countries like ours. Population aging and longer life expectancy […]

Read more →

Granting of two projects of the Health Research Fund FIS to the Nanomedicine group

1 de October de 2019

The multidisciplinary research group of nanomedicine-IDIVAL belonging to the NanoBioAp network (@NanoBioAp) has just won two research projects in the AES2019 call (PI19 / 00496 and DTS19 / 00033). Their objective is to develop a precision system for the diagnosis and non-invasive therapy of head and neck cancer. It is estimated that the incidence is […]

Read more →

Concession of a Health Research Fund FIS project to the Transplant and Autoimmunity group

30 de September de 2019

The research project led by Dr. López Hoyos (Transplant and Autoimmunity group) entitled “Prevalence of post-transplant solid organ non-alcoholic steatohepatitis. Involvement of the innate and adaptive immune response” has obtained funding from the Carlos III Health Institute in the last call of the recently resolved National Plan. The prevalence of fatty liver disease (NAFLD) is […]

Read more →

They develop a device that allows performing robotic surgery assisted by pelvic navigation

27 de September de 2019

Surgeons at the Marqués de Valdecilla University Hospital (HUMV) have developed, with the advice of the IDIVAL Innovation Support Unit that belongs to the ITEMAS Platform, an arc-shaped device that allows surgery performed in the pelvis at the same time that are operated, with robotic assistance, pathologies in the organs of this same part of […]

Read more →